PFG
CELG

Piershale Financial Group’s Celgene Corp CELG Stock Holding History

Piershale Financial Group’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-150
Closed -$16K – 168
2016
Q3 		$16K Buy
+150
New +$16.2K 0.01% 76
2016
Q1 		– Sell
-100
Closed -$12K – 231
2015
Q4 		$12K Buy
+100
New +$11.6K 0.01% 109
2015
Q3 		– Sell
-175
Closed -$20K – 188
2015
Q2 		$20K Hold
175
– – 0.02% 52
2015
Q1 		$20K Hold
175
– – 0.02% 57
2014
Q4 		$20K Buy
175
+75
+75% +$7.91K 0.01% 69
2014
Q3 		$9K Buy
+100
New +$9.02K 0.01% 93

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Piershale Financial Group's CELG Position: Q4 2016 in Review

Piershale Financial Group sold out of Celgene Corp (CELG) in Q4 2016, closing a stake of 150 shares — an estimated $16K sold.

Piershale Financial Group first reported a position in CELG in Q3 2014 and held it in 6 quarters. The position peaked at $20K in Q2 2015. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

  • Piershale Financial Group reported no remaining Celgene Corp position as of Q4 2016 after selling out during the quarter.
  • Piershale Financial Group sold 150 Celgene Corp shares in Q4 2016, an estimated $16K.
  • Piershale Financial Group first reported a position in Celgene Corp in Q3 2014 and held it in 6 quarters.
  • Piershale Financial Group's Celgene Corp position peaked at $20K in Q2 2015.
  • 1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on Piershale Financial Group's 13F filing for Q4 2016, filed 18 Jan 2017.